The Effect of Predictive Testing in Adult-Onset Neurodegenerative Diseases on Social and Personal Life
Follow-up studies on predictive testing for hereditary neurodegenerative diseases mainly focussed on psychological outcomes. We investigated whether the social and personal life of mutation carriers differ negatively from non-carriers and untested at-risk individuals. Asymptomatic individuals (≥ 35 years) who received a genetic test result for Huntington’s disease, frontotemporal dementia or Alzheimer’s disease more than 2 years before the onset of the study and untested subjects at 50% risk were invited to complete a questionnaire and an additional questionnaire with extra or adjusted items. Of the 283 selected individuals, 115 returned a positive informed consent (response rate 39.6%). Of these, 17 carriers, 30 non-carriers and 27 untested persons (n = 74) fulfilled the criteria and completed both questionnaires. We found no significant differences in employment, financial situation and lifestyle or anxiety and depression between carriers and non-carriers or untested individuals at risk. Carriers were more often single and childless, though these differences were not significant. The findings of this study suggest that the result of predictive testing on adult-onset neurodegenerative diseases does not have a large negative effect on social and personal life, although these observations should be interpreted with caution because of the small number of participants and low response rate.
KeywordsDementia Frontotemporal dementia Genetic testing Huntington’s disease Neurodegenerative disease Socioeconomic factors
We thank Reinier Timman and Lidewij Henneman for their advice on the design of the study and the questionnaires. This work was conducted to fulfill a degree requirement.
Compliance with Ethical Standards
Conflicts of Interest
PC, JvS, YP, AT, HM and AK declare that they have no conflict of interest.
Human Studies and Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
No animals have been used in this study.
- Clark, R. F., Hutton, M., Fuldner, M., Froelich, S., Karran, E., Talbot, C., et al. (1995). The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Alzheimer’s Disease Collaborative Group. Nature Genetics, 11, 219–222.CrossRefGoogle Scholar
- Erwin, C., Williams, J. K., Juhl, A. R., Mengeling, M., Mills, J. A., Bombard, Y., et al. (2010). Perception, experience, and response to genetic discrimination in Huntington disease: the international RESPOND-HD study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153B, 1081–1093.Google Scholar
- Gandek, B., Ware, J. E., Aaronson, N. K., Apolone, G., Bjorner, J. B., Brazier, J. E., et al. (1998). Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology, 51, 1171–1178.PubMedGoogle Scholar
- Penziner, E., Williams, J. K., Erwin, C., Bombard, Y., Wallis, A., Beglinger, L. J., et al. (2008). Perceptions of discrimination among persons who have undergone predictive testing for Huntington’s disease. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 147, 320–325.CrossRefGoogle Scholar
- Renton, A. E., Majounie, E., Waite, A., Simon-Sanchez, J., Rollinson, S., Gibbs, J. R., et al. (2011). A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron, 72(2), 257–268. https://doi.org/10.1016/j.neuron.2011.09.010.
- Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998). Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proceedings of the National Academy of Sciences of the United States of America, 95, 7737–7741.CrossRefPubMedPubMedCentralGoogle Scholar
- Statistics Netherlands (2016) [online publication]. Retrieved from http://statline.cbs.nl/Statweb/?LA=en
- Williams, J. K., Erwin, C., Juhl, A. R., Mengeling, M., Bombard, Y., Hayden, M. R., et al. (2010). In their own words: reports of stigma and genetic discrimination by people at risk for Huntington disease in the International RESPOND-HD study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153B, 1150–1159.Google Scholar